title: NSAIDs and Alzheimer's disease: how far to generalise from trials?
authors.affiliation: GRECC (S-182), VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, USA. jcsb@u.washington.edu
authors.forename: John C S
authors.initials: JC
authors.lastname: Breitner
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000517:prevention & control; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000068579:Celecoxib; D006801:Humans; D009288:Naproxen / Q000627:therapeutic use; D011720:Pyrazoles; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011720:Pyrazoles; D013449:Sulfonamides; D009288:Naproxen; D000068579:Celecoxib